Detalhe da pesquisa
1.
Ribociclib plus Endocrine Therapy in Early Breast Cancer.
N Engl J Med
; 390(12): 1080-1091, 2024 Mar 21.
Artigo
Inglês
| MEDLINE | ID: mdl-38507751
2.
Neoadjuvant trastuzumab, pertuzumab, and chemotherapy versus trastuzumab emtansine plus pertuzumab in patients with HER2-positive breast cancer (KRISTINE): a randomised, open-label, multicentre, phase 3 trial.
Lancet Oncol
; 19(1): 115-126, 2018 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29175149
3.
Imaging Radiation Doses and Associated Risks and Benefits in Subjects Participating in Breast Cancer Clinical Trials.
Oncologist
; 20(7): 702-12, 2015 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-26025934
4.
Planning cancer control in Latin America and the Caribbean.
Lancet Oncol
; 14(5): 391-436, 2013 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-23628188
5.
6.
Rationale and trial design of NATALEE: a Phase III trial of adjuvant ribociclib + endocrine therapy versus endocrine therapy alone in patients with HR+/HER2- early breast cancer.
Ther Adv Med Oncol
; 15: 17588359231178125, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37275963
7.
Intensive Imaging Surveillance of Survivors of Breast Cancer May Increase Risk of Radiation-induced Malignancy.
Clin Breast Cancer
; 19(3): e468-e474, 2019 06.
Artigo
Inglês
| MEDLINE | ID: mdl-30850181
8.
EPIDEMIOLOGY AND TREATMENT OF MONTEGGIA LESION IN ADULTS: SERIES OF 44 CASES.
Acta Ortop Bras
; 24(1): 48-51, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-26997915
9.
Synchronous presentation of an Askin tumor and a plasmacytoma in an adult patient.
Tumori
; 89(3): 324-7, 2003.
Artigo
Inglês
| MEDLINE | ID: mdl-12908792
10.
EPIDEMIOLOGY AND TREATMENT OF MONTEGGIA LESION IN ADULTS: SERIES OF 44 CASES
Acta ortop. bras
; 24(1): 48-51, Jan.-Feb. 2016. tab
Artigo
Inglês
| LILACS | ID: lil-771863
11.
Final Survival Analysis of ROSE/TRIO-012.
J Clin Oncol
; 34(30): 3714-3715, 2016 Oct 20.
Artigo
Inglês
| MEDLINE | ID: mdl-27480148
12.
Cambios en la densidad mineral ósea en pacientes que reciben terapia de deprivación androgénica para el cáncer de próstata / Changes in bone mineral density in patients receiving androgen deprivation therapy for prostate cancer
Rev. méd. Urug
; 31(4): 249-258, dic. 2015. ilus, tab
Artigo
Espanhol
| LILACS | ID: lil-778611
13.
Reply to H.J. Lee et al.
J Clin Oncol
; 33(24): 2712-3, 2015 Aug 20.
Artigo
Inglês
| MEDLINE | ID: mdl-26195708
14.
Análisis de sobrevida según perfil biológico de pacientes uruguayas con cáncer de mama / Survival data analysis by biological profile of uruguayan patients with breast cancer
Rev. méd. Urug
; 28(4): 241-9, dic. 2012. tab, graf
Artigo
Espanhol
| LILACS | ID: lil-667772
15.
Expresión tumoral de HER-2, receptores de estrógenos y de progesterona y su relación con características clínico-patológicas en pacientes uruguayas con cáncer de mama / Tumor expression of HER-2, estrogen and progesterone receptors and their relationship with clinical-pathological characteristics in Uruguayan patients with breast cancer
Rev. méd. Urug
; 26(3): 145-153, set. 2010. tab
Artigo
Espanhol
| LILACS | ID: biblio-961486
16.
Seguimiento en cáncer de colon: ¿cómo y hasta cuándo? / Follow up in colon cancer: how and until when?
Rev. argent. coloproctología
; 16(1): 32-39, 2005. tab, graf
Artigo
Espanhol
| LILACS | ID: lil-421468
17.
Seguimiento en cáncer de colon: ¿cómo y hasta cuándo? / Follow up in colon cancer: how and until when?
Rev. argent. coloproctología
; 16(1): 32-39, 2005. tab, graf
Artigo
Espanhol
| BINACIS | ID: bin-853
18.
Recomendaciones para la prevención y el tratamiento de náuseas y vómitos inducidos por quimioterapia / Nausea and vomiting induced by chemotherapy: prevention and treatment guidelines
Rev. méd. Urug
; 20(2): 120-129, ago. 2004. tab
Artigo
Espanhol
| LILACS | ID: lil-384552